Influence of iron regulation on the metabolome of cryptococcus neoformans

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Choi, Jung Nam ^a   Kim, Jeongmi ^b   Kim, Jiyoung ^a   Jung, Won Hee ^b   Lee, Choong Hwan ^a  

^a Konkuk University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOSTEROL; INOSITOL; INOSITOL OXYGENASE; IRON REGULATORY FACTOR; METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE (ACYLATING); PROTEIN CIR1; UNCLASSIFIED DRUG;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME METABOLISM; ENZYME SYNTHESIS; FUNGAL STRAIN; GENE EXPRESSION; GLUCOSE METABOLISM; GLYCOLYSIS; MASS FRAGMENTOGRAPHY; METABOLOME; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; SEQUENCE ALIGNMENT;

ANTIFUNGAL AGENTS; AZOLES; CRYPTOCOCCUS NEOFORMANS; DISCRIMINANT ANALYSIS; ERGOSTEROL; FUNGAL PROTEINS; GLYCOLYSIS; HUMANS; INOSITOL; IRON; IRON-REGULATORY PROTEINS; LEAST-SQUARES ANALYSIS; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MICROBIAL SENSITIVITY TESTS; MUTATION; PRINCIPAL COMPONENT ANALYSIS;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 84864246794     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041654     Document Type: Article

References (33)

1. Philpott CC, Leidgens S, Frey AG, (2012) Metabolic remodeling in iron-deficient fungi. Biochim Biophys Acta.
2. Philpott CC, (2006) Iron uptake in fungi: a system for every source. Biochim Biophys Acta 1763: 636-645.
3. Schaible UE, Kaufmann SH, (2004) Iron and microbial infection. Nat Rev Microbiol 2: 946-953.
4. Jung WH, Sham A, White R, Kronstad JW, (2006) Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol 4: e410.
5. Jung WH, Sham A, Lian T, Singh A, Kosman DJ, et al. (2008) Iron source preference and regulation of iron uptake in Cryptococcus neoformans. PLoS Pathog 4: e45.
6. Jung WH, Hu G, Kuo W, Kronstad JW, (2009) Role of ferroxidases in iron uptake and virulence of Cryptococcus neoformans. Eukaryot Cell 8: 1511-1520.
7. Kusano M, Fukushima A, Arita M, Jonsson P, Moritz T, et al. (2007) Unbiased characterization of genotype-dependent metabolic regulations by metabolomic approach in Arabidopsis thaliana. BMC Syst Biol 1: 53.
8. Choi YH, Kim HK, Hazekamp A, Erkelens C, Lefeber AW, et al. (2004) Metabolomic differentiation of Cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis. J Nat Prod 67: 953-957.
9. Villas-Boas SG, Noel S, Lane GA, Attwood G, Cookson A, (2006) Extracellular metabolomics: a metabolic footprinting approach to assess fiber degradation in complex media. Anal Biochem 349: 297-305.
10. Scherling C, Roscher C, Giavalisco P, Schulze ED, Weckwerth W, (2010) Metabolomics unravel contrasting effects of biodiversity on the performance of individual plant species. PLoS One 5: e12569.
11. Shakoury-Elizeh M, Protchenko O, Berger A, Cox J, Gable K, et al. (2010) Metabolic response to iron deficiency in Saccharomyces cerevisiae. J Biol Chem 285: 14823-14833.
12. Gao X, Pujos-Guillot E, Martin JF, Galan P, Juste C, et al. (2009) Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. Anal Biochem 393: 163-175.
13. Tikunov Y, Lommen A, de Vos CH, Verhoeven HA, Bino RJ, et al. (2005) A novel approach for nontargeted data analysis for metabolomics. Large-scale profiling of tomato fruit volatiles. Plant Physiol 139: 1125-1137.
14. Katajamaa M, Oresic M, (2005) Processing methods for differential analysis of LC/MS profile data. BMC Bioinformatics 6: 179.
15. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, et al. (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6: 1060-1083.
16. Kim DH, Jarvis RM, Xu Y, Oliver AW, Allwood JW, et al. (2010) Combining metabolic fingerprinting and footprinting to understand the phenotypic response of HPV16 E6 expressing cervical carcinoma cells exposed to the HIV anti-viral drug lopinavir. Analyst 135: 1235-1244.
17. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, et al. (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396-400.
18. Kouskoumvekaki I, Panagiotou G, (2011) Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules. J Biomed Biotechnol 2011.
19. Puig S, Askeland E, Thiele DJ, (2005) Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell 120: 99-110.
20. Nohturfft A, Zhang SC, (2009) Coordination of lipid metabolism in membrane biogenesis. Annu Rev Cell Dev Biol 25: 539-566.
21. Ghannoum MA, Rice LB, (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517.
22. Hitchcock CA, Barrett-Bee KJ, Russell NJ, (1987) The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans. J Med Vet Mycol 25: 29-37.
23. Reynolds TB, (2009) Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it. Microbiology 155: 1386-1396.
24. Luberto C, Toffaletti DL, Wills EA, Tucker SC, Casadevall A, et al. (2001) Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev 15: 201-212.
25. Shea JM, Kechichian TB, Luberto C, Del Poeta M, (2006) The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect Immun 74: 5977-5988.
26. Xue C, Liu T, Chen L, Li W, Liu I, et al. (2010) Role of an expanded inositol transporter repertoire in Cryptococcus neoformans sexual reproduction and virulence. MBio 1.
27. Xue C, Tada Y, Dong X, Heitman J, (2007) The human fungal pathogen Cryptococcus can complete its sexual cycle during a pathogenic association with plants. Cell Host Microbe 1: 263-273.
28. Shetty HU, Holloway HW, Schapiro MB, (1996) Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin Chem 42: 298-302.
29. Spector R, Lorenzo AV, (1975) Myo-inositol transport in the central nervous system. Am J Physiol 228: 1510-1518.
30. Spector R, Lorenzo AV, (1975) The origin of myo-inositol in brain, cerebrospinal fluid and choroid plexus. J Neurochem 25: 353-354.
31. Wang Y, Liu TB, Delmas G, Park S, Perlin D, et al. (2011) Two major inositol transporters and their role in cryptococcal virulence. Eukaryot Cell 10: 618-628.
32. Chen YL, Kauffman S, Reynolds TB, (2008) Candida albicans uses multiple mechanisms to acquire the essential metabolite inositol during infection. Infect Immun 76: 2793-2801.
33. Ghannoum MA, (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13: 122-143, table of contents.